In this article, we found that some word expressions were wrong and inappropriate. We apologize for any inconvenience or confusion caused by these errors. The correct version is shown as Erratum Table (Table 1) below.
Table 1.
Pre- and post-modification comparisons
| Before modification | After modification | Page |
|---|---|---|
| Figure 3. IL-17 promotes ovarian cancer apoptosis. A. In nude mice, the tunel test was performed, and positive cells increased in the Secukinumab and Pterostilbene groups; B. The tumor volume increased in the Secukinumab and Pterostilbene groups compared with the control group after the first week of injection; C. Apoptotic rates decreased in the IL-17 group, *P < 0.05. | Figure 3. IL-17 inhibits ovarian cancer apoptosis. A. In nude mice, the tunel test was performed, and positive cells increased in the Secukinumab and Pterostilbene groups; B. The tumor volume decreased in the Secukinumab and Pterostilbene groups compared with the control group after the first week of injection; C. Apoptotic rates decreased in the IL-17 group, *P < 0.05. | Page 5652 |
| IL-17 promotes apoptosis of ovarian cancer cells | IL-17 inhibits apoptosis of ovarian cancer cells | Page 5650 |
| To further understand the role of IL-17 in promoting ovarian cancer cell apoptosis in ovarian cancer cells | To further understand the role of IL-17 in inhibiting ovarian cancer cell apoptosis in ovarian cancer cells | Page 5650 |
| We found that the tumor volume increased in the Secukinumab and Pterostilbene groups compared with the control group after the first week of injection | We found that the tumor volume decreased in the Secukinumab and Pterostilbene groups compared with the control group after the first week of injection | Page 5650 |
| we found that IL-17-induced migration, invasion, and apoptosis of CAOV-3 and OVCAR-3 cells, and the tumor volume increased in the Secukinumab and Pterostilbene groups compared with the control group after the first week of injection | we found that IL-17-induced migration, invasion, and inhibited apoptosis of CAOV-3 and OVCAR-3 cells, and the tumor volume decreased in the Secukinumab and Pterostilbene groups compared with the control group after the first week of injection | Page 5655 |